The Swiss-based pharmaceutical giant Novartis is taking the state of India to court in a case that has, after rumbling about in the lower courts for six years, wound up as a very public litmus test of the legal framework sustaining India’s generic drugs revolution. With the case due before the Supreme Court on 28 March, the fate of millions who depend on affordable Indian medicines may soon hang in the...
More »SEARCH RESULT
Superweeds, superpests and superprofits by Vandana Shiva
New research from Navdanya and from the US Union of Concerned Scientists proves that Bt cotton yields are actually a third of what Monsanto claims. Genetic engineering is not going to help feed the world, writes Vandana Shiva, but it is going to harm public health and ecosystems We have been repeatedly told that genetically engineered (GE) crops will save the world. They will save the world by increasing yields and...
More »India’s drug ‘lifeline’ under threat by Mari Marcel Thekaekara
I never dreamed I’d ever wave the flag for Indian pharmaceutical companies. But some years ago, I discovered that India provides essential drugs to most of the world’s economically deprived nations. Many of the poorest people in India and Africa could not afford basic drugs if it were not for Indian drug companies. Astonishingly, India is known as the ‘pharmacy to the developing world’ and is something of a hero in...
More »"BRICS Can Ensure Affordable Drugs" by Ranjit Devraj
While ‘data exclusivity’ clauses will not feature in the India-European Union free trade agreement (FTA), the threat posed by the impending deal to the world’s supply of cheap generic drugs is far from over. India’s commerce and industry minister Anand Sharma assured Michel Sidibe, chief of the United Nations joint programme on HIV and AIDS (UNAIDS) at a meeting this week that India would reject attempts by pharmaceutical giants to include...
More »MNC pharma firms campaigning against Indian cos: govt
The government today said multi national companies (MNCs) are campaigning against domestic pharma industry as their interests were getting impacted due to increasing global presence of Indian firms in the generic segment. In a written reply to the Lok Sabha, Minister of State for Commerce and Industry Jyotiraditya Scindia said: "A concerted campaign against India pharma industry has been launched by MNCs whose interests are getting adversely impacted due to increasing...
More »